查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球細胞表面標記物市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1332672

全球細胞表面標記物市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Cell Surface Markers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 221 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2030 年，全球細胞表面標記市場的市場規模將從 2022 年的 749.86 百萬美元達到近 1549.87 百萬美元，2023-2030 年研究期間年複合成長率為 9.5%。

細胞表面標記，也稱為細胞表面抗原或膜標記，是存在於細胞外表面的蛋白質或分子。這些標記物有多種用途，包括細胞之間的識別、通訊和相互作用，以及用於診斷和治療目的。它們在免疫學中發揮著重要作用，因為它們有助於區分不同的細胞類型，並使免疫系統能夠識別外來物質或病原體並對其做出反應。這些標記還可以深入了解細胞的生理狀態、發育階段及其在組織和器官內的特定功能。

市場動態：

不斷發展的細胞生物學和免疫學研究需要準確的工具來識別和分析細胞表面標記，從而揭示細胞功能和相互作用。細胞標記物對於了解免疫反應和開發靶向癌症療法至關重要，從而刺激了對錶徵免疫細胞和疾病亞型的工具的需求。細胞標記物有助於疾病亞型識別，符合個性化醫療對基於個體患者概況的客製化治療的需求。疾病相關標記物的識別推動了診斷測試和標靶治療，吸引了生物技術和製藥領域的興趣。改進的抗體技術、成像方法和數據分析增強了細胞標記物檢測和分析能力。標記物指導幹細胞識別和分化階段，這對於再生醫學應用至關重要。產學合作和資金注入支持這一充滿活力的領域的研究和生物技術創新。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球細胞表面標記市場的每個細分市場進行了包容性評估。細胞表面標記物行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的細胞表面標記物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。細胞表面標記物市場的主要參與者包括 Thermo Fisher Scientific（美國）、QIAGEN NV（荷蘭）、Becton、Dickinson and Company（美國）、F. Hoffman-La Roche（瑞士）、Bio-Rad Laboratories（美國）、丹納赫公司（美國）、Abcam（英國）、金斯瑞（中國）、BioLegend（美國）、Cell Signaling Technology（美國）、Marck KGaA（德國）、Bio-Techne（美國）。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：細胞表面標記 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按來源分類的市場吸引力分析
    • 按電池類型分類的市場吸引力分析
    • 市場吸引力分析：按應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：全球細胞表面標記物市場分析：按產品分類

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 抗體
  • PCR陣列

第 6 章：全球細胞表面標記物市場分析：按來源分類

  • 按來源概述
  • 歷史和預測數據
  • 按來源分析
  • 老鼠
  • 鼠

第 7 章：全球細胞表面標記物市場分析：按細胞類型

  • 按細胞類型概述
  • 歷史和預測數據
  • 按細胞類型分析
  • T細胞
  • B細胞
  • NK細胞

第 8 章：全球細胞表面標記物市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 研究（幹細胞、免疫學）
  • 臨床（腫瘤學、血液學）

第 9 章：全球細胞表面標記物市場分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院

第 10 章：全球細胞表面標記物市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史和預測數據銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章：細胞表面標記物公司的競爭格局

  • 細胞表面標記物市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Thermo Fisher Scientific (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • QIAGEN NV (Netherlands)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Becton
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Dickinson and Company (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffman-La Roche (Switzerland)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Rad Laboratories (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Danaher Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abcam (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • GenScript (China)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BioLegend (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cell Signaling Technology (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Marck KGaA (Germany)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Techne (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR112111916

The global demand for Cell Surface Markers Market is presumed to reach the market size of nearly USD 1549.87 MN by 2030 from USD 749.86 MN in 2022 with a CAGR of 9.5% under the study period 2023 - 2030.

Cell surface markers, also known as cell surface antigens or membrane markers, are proteins or molecules present on the outer surface of cells. These markers serve various purposes, including identification, communication, and interaction between cells, as well as being used for diagnostic and therapeutic purposes. These play a significant role in immunology, as they help distinguish different cell types and allow the immune system to recognize and respond to foreign substances or pathogens. These markers can also provide insights into the physiological state of cells, their developmental stage, and their specific functions within tissues and organs.

MARKET DYNAMICS:

Evolving cell biology and immunology research demand accurate tools to identify and analyze cell surface markers, shedding light on cell functions and interactions. Cell markers are critical for understanding immune responses and developing targeted cancer therapies, fueling demand for tools to characterize immune cells and disease subtypes. Cell markers aid disease subtype identification, aligning with personalized medicine's need for tailored treatments based on individual patient profiles. Identification of disease-associated markers drives diagnostic tests and targeted therapies, attracting interest from the biotech and pharmaceutical sectors. Improved antibody tech, imaging methods, and data analysis enhance cell marker detection and analysis capabilities. Markers guide stem cell identification and differentiation stages, which are vital for regenerative medicine applications. Industry-academia collaboration and funding injections support research and biotechnology innovations in this dynamic field.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell surface markers. The growth and trends of cell surface markers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell surface markers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Antibody
  • PCR Array

By Source

  • Mice
  • Rat

By Cell Type

  • T Cells
  • B Cells
  • NK Cell

By Application

  • Research (Stem Cell, Immunology)
  • Clinical (Oncology, Hematology)

By End User

  • Hospitals

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Surface Markers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Surface Markers market include Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Marck KGaA (Germany), Bio-Techne (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CELL SURFACE MARKERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Source
    • 3.7.3 Market Attractiveness Analysis By Cell Type
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Antibody Historic and Forecast Sales by Regions
  • 5.5 PCR Array Historic and Forecast Sales by Regions

6 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY SOURCE

  • 6.1 Overview by Source
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Source
  • 6.4 Mice Historic and Forecast Sales by Regions
  • 6.5 Rat Historic and Forecast Sales by Regions

7 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY CELL TYPE

  • 7.1 Overview by Cell Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Cell Type
  • 7.4 T Cells Historic and Forecast Sales by Regions
  • 7.5 B Cells Historic and Forecast Sales by Regions
  • 7.6 NK Cell Historic and Forecast Sales by Regions

8 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Research (Stem Cell, Immunology) Historic and Forecast Sales by Regions
  • 8.5 Clinical (Oncology, Hematology) Historic and Forecast Sales by Regions

9 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Hospitals Historic and Forecast Sales by Regions

10 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE CELL SURFACE MARKERS COMPANIES

  • 11.1. Cell Surface Markers Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF CELL SURFACE MARKERS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific (US)
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. QIAGEN N.V. (Netherlands)
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Becton
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Dickinson and Company (US)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. F. Hoffman-La Roche (Switzerland)
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Bio-Rad Laboratories (US)
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Danaher Corporation (US)
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Abcam (UK)
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. GenScript (China)
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. BioLegend (US)
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Cell Signaling Technology (US)
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Marck KGaA (Germany)
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Bio-Techne (US)
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Product (USD MN)
  • Antibody Market Sales by Geography (USD MN)
  • PCR Array Market Sales by Geography (USD MN)
  • Analysis Market by Source (USD MN)
  • Mice Market Sales by Geography (USD MN)
  • Rat Market Sales by Geography (USD MN)
  • Analysis by Cell Type (USD MN)
  • T Cells Market Sales by Geography (USD MN)
  • B Cells Market Sales by Geography (USD MN)
  • NK Cell Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Research (Stem Cell, Immunology) Market Sales by Geography (USD MN)
  • Clinical (Oncology, Hematology) Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Global Cell Surface Markers Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cell Surface Markers Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell Surface Markers Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Source
  • Market Attractiveness Analysis by Cell Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Antibody Market Sales by Geography (USD MN)
  • PCR Array Market Sales by Geography (USD MN)
  • Global Market Analysis by Source (USD MN)
  • Mice Market Sales by Geography (USD MN)
  • Rat Market Sales by Geography (USD MN)
  • Global Market Analysis by Cell Type (USD MN)
  • T Cells Market Sales by Geography (USD MN)
  • B Cells Market Sales by Geography (USD MN)
  • NK Cell Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Research (Stem Cell, Immunology) Market Sales by Geography (USD MN)
  • Clinical (Oncology, Hematology) Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.